DexCom, Inc.
DXCM
Peringkat dalam Saham
#753
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Harga Saham
$85.90
Kapitalisasi Pasar
$32.42B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
28.98%
Negara
US
Perdagangan DexCom, Inc. (DXCM)
Kategori
Healthcare
EPS untuk DexCom, Inc. (DXCM)
EPS per June 2026 TTM: $2.59
Menurut laporan keuangan terbaru dan harga saham DexCom, Inc., EPS perusahaan saat ini (TTM) adalah $2.59. Pada akhir 2024, perusahaan memiliki EPS sebesar $1.46 peningkatan dibandingkan EPS tahun 2023 sebesar $1.44.
Riwayat EPS untuk DexCom, Inc. dari 2000 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $2.59 | 21.03% |
| 2025 | $2.14 | 46.58% |
| 2024 | $1.46 | 1.39% |
| 2023 | $1.44 | 63.64% |
| 2022 | $0.88 | 57.14% |
| 2021 | $0.56 | -57.25% |
| 2020 | $1.31 | 367.86% |
| 2019 | $0.28 | -177.78% |
| 2018 | $-0.36 | 140.00% |
| 2017 | $-0.15 | -25.00% |
| 2016 | $-0.20 | 11.11% |
| 2015 | $-0.18 | 141.61% |
| 2014 | $-0.07 | -25.50% |
| 2013 | $-0.10 | -50.00% |
| 2012 | $-0.20 | 17.65% |
| 2011 | $-0.17 | -29.17% |
| 2010 | $-0.24 | -20.00% |
| 2009 | $-0.30 | -36.17% |
| 2008 | $-0.47 | 14.63% |
| 2007 | $-0.41 | -4.65% |
| 2006 | $-0.43 | 4.88% |
| 2005 | $-0.41 | -73.20% |
| 2004 | $-1.53 | 34.21% |
| 2003 | $-1.14 | 21.28% |
| 2002 | $-0.94 | 13.25% |
| 2001 | $-0.83 | 45.61% |
| 2000 | $-0.57 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $3.11 | 20.08% |
US
|
|
| $3.59 | 38.61% |
IE
|
|
| $9.73 | 275.68% |
US
|
|
| $2.48 | -4.25% |
US
|
|
| - | - |
DE
|
